High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients (Q40372616)

16 June 2018

title

High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients (English)

1 reference

16 June 2018

1 reference

13

1 reference

19 September 2017

T Kumar

8

0 references

Vincent Bernard

object named as

V Bernard

6

0 references

Vladimír Janout

14

object named as

V Janout

1 reference

16 June 2018

12

E Fabianova

1 reference

16 June 2018

19

P Brennan

1 reference

16 June 2018

K Allenson

1

1 reference

16 June 2018

J Castillo

2

1 reference

16 June 2018

F A San Lucas

3

1 reference

16 June 2018

G Scelo

4

1 reference

16 June 2018

D U Kim

5

1 reference

16 June 2018

G Davis

7

1 reference

16 June 2018

M Katz

9

1 reference

16 June 2018

M J Overman

10

1 reference

16 June 2018

L Foretova

11

1 reference

16 June 2018

F Meric-Bernstam

15

1 reference

16 June 2018

P Gascoyne

16

1 reference

16 June 2018

I Wistuba

17

1 reference

16 June 2018

G Varadhachary

18

1 reference

16 June 2018

S Hanash

20

1 reference

16 June 2018

D Li

21

1 reference

16 June 2018

A Maitra

22

1 reference

16 June 2018

H Alvarez

23

1 reference

16 June 2018

publication date

1 April 2017

1 reference

16 June 2018

published in

Annals of Oncology

1 reference

16 June 2018

volume

28

1 reference

16 June 2018

issue

4

1 reference

16 June 2018

page(s)

741-747

1 reference

16 June 2018

Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Exosomes: potential for early detection in pancreatic cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

17 June 2018

Cancer statistics, 2016

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Current and Future Approaches to Target the Epidermal Growth Factor Receptor and Its Downstream Signaling in Metastatic Colorectal Cancer.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Detection of circulating tumor DNA in early- and late-stage human malignancies

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Microvesicles and exosomes for intracardiac communication

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Liquid biopsies: genotyping circulating tumor DNA

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Progress in breast cancer: overview

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Clinical practice. Breast-cancer screening

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Current status of molecular markers for early detection of sporadic pancreatic cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Clinical practice. Screening for colorectal cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Follow-up study of K-ras mutations in the plasma of patients with pancreatic cancer: correlation with clinical features and carbohydrate antigen 19-9.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

A prospective study of K-ras mutations in the plasma of pancreatic cancer patients

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Pancreatic Adenocarcinoma

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834026

K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance

20 August 2018

1 reference

12 December 2020

A Word of Caution on New and Revolutionary Diagnostic Tests

1 reference

12 December 2020

K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer

1 reference

12 December 2020

A prospective study of detection of pancreatic carcinoma by combined plasma K-ras mutations and serum CA19-9 analysis

1 reference

12 December 2020

Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1093/ANNONC/MDX004

1 reference

16 June 2018

PMCID

5834026

1 reference

16 June 2018

PubMed ID

28104621

1 reference

16 June 2018